IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 62 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $428,000 | +28.5% | 167,318 | -23.1% | 0.00% | – |
Q2 2016 | $333,000 | -31.6% | 217,445 | -11.5% | 0.00% | – |
Q1 2016 | $487,000 | -40.0% | 245,825 | -6.4% | 0.00% | -100.0% |
Q4 2015 | $811,000 | -41.0% | 262,614 | -36.0% | 0.00% | 0.0% |
Q3 2015 | $1,374,000 | -37.3% | 410,054 | -30.6% | 0.00% | 0.0% |
Q2 2015 | $2,193,000 | -23.3% | 591,231 | -23.3% | 0.00% | -50.0% |
Q1 2015 | $2,861,000 | -15.9% | 771,180 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $3,401,000 | +70.6% | 771,180 | -11.4% | 0.00% | +100.0% |
Q3 2014 | $1,994,000 | -29.0% | 870,629 | -10.1% | 0.00% | -50.0% |
Q2 2014 | $2,809,000 | -29.1% | 968,484 | -0.3% | 0.00% | -33.3% |
Q1 2014 | $3,964,000 | -12.5% | 971,650 | -0.7% | 0.00% | -25.0% |
Q4 2013 | $4,529,000 | +165.0% | 978,091 | -0.4% | 0.00% | +300.0% |
Q3 2013 | $1,709,000 | +160.1% | 982,055 | -2.1% | 0.00% | 0.0% |
Q2 2013 | $657,000 | – | 1,003,032 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|